{"result": {"id": "e9642353-d397-4c7b-981f-a51d43b95d92", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"ACTION TRIAL and Researchers\",\n    \"summary\": \"The community centers around the ACTION TRIAL, a clinical trial investigating the effects of long-acting nifedipine on patients with symptomatic stable angina and hypertension. Key entities include researchers LUBSEN J, WAGENER G, and KIRWAN BA, who were involved in the trial. The trial's findings were published in the Journal of Hypertension, indicating its significance in the medical research community.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the potential implications of the trial's findings on patient treatment and cardiovascular health.\",\n    \"findings\": [\n        {\n            \"summary\": \"ACTION TRIAL's primary objective\",\n            \"explanation\": \"The ACTION TRIAL aimed to investigate the effects of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension. This trial's focus on a specific patient population and its potential to influence treatment protocols underscore its importance in the medical field. [Data: Entities (3349)]\"\n        },\n        {\n            \"summary\": \"Key researchers involved in the ACTION TRIAL\",\n            \"explanation\": \"Researchers LUBSEN J, WAGENER G, and KIRWAN BA played significant roles in the ACTION TRIAL. Their involvement highlights the collaborative effort behind the trial's research into the effects of nifedipine. The leadership and participation of these researchers were crucial to the trial's execution and findings. [Data: Entities (3384, 3385, 3386), Relationships (3474, 3479, 3480)]\"\n        },\n        {\n            \"summary\": \"Publication of trial findings\",\n            \"explanation\": \"The ACTION TRIAL's findings were published in the Journal of Hypertension, a reputable source in the medical community. This publication signifies the trial's contribution to the understanding of nifedipine's effects and its potential impact on treatment strategies for patients with angina and hypertension. [Data: Relationships (3473)]\"\n        },\n        {\n            \"summary\": \"Potential implications of the trial's findings\",\n            \"explanation\": \"The ACTION TRIAL's investigation into long-acting nifedipine could have significant implications for the treatment of patients with symptomatic stable angina and hypertension. The trial's focus on mortality and cardiovascular morbidity outcomes suggests its findings could influence future treatment protocols and patient care strategies. [Data: Entities (3349)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751560088, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 518, "prompt_tokens": 2518, "total_tokens": 3036, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1472}, "prompt_cache_hit_tokens": 1472, "prompt_cache_miss_tokens": 1046}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n3349,ACTION TRIAL,\"The **ACTION TRIAL** is a clinical trial that investigated the effects of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension. The study aimed to assess the impact of this treatment on patient outcomes, focusing on both survival rates and cardiovascular health complications. Both descriptions confirm the trial's primary objective, emphasizing its role in evaluating the efficacy of long-acting nifedipine in this specific patient population.  \n\nThe summary consolidates the provided descriptions into a coherent overview, ensuring clarity and consistency while retaining all key details.\",4\n3384,LUBSEN J,\"LUBSEN J is a researcher who was involved in the ACTION trial, a study focused on investigating the effects of nifedipine. The descriptions highlight their participation in this clinical trial, though no additional details about their specific role or contributions are provided. Both descriptions consistently identify LUBSEN J's association with the ACTION trial, reinforcing their involvement in this research.\",1\n3385,WAGENER G,\"WAGENER G is a researcher who was involved in the ACTION trial, a study focused on investigating the effects of nifedipine. The descriptions consistently highlight their participation in this clinical trial, emphasizing their role in researching the impact of the medication. No contradictory information was provided.\",1\n3386,KIRWAN BA,\"KIRWAN BA is a researcher who was involved in the ACTION trial, a study focused on investigating the effects of nifedipine. The trial examined the impact and potential benefits of this medication, with KIRWAN BA contributing to its research efforts. Both descriptions confirm their participation in this clinical study, reinforcing their role in the project.\",1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n3473,ACTION TRIAL,J HYPERTENS,The trial's findings were published in the Journal of Hypertension,20\n3474,ACTION TRIAL,LUBSEN J,\"The ACTION trial was a study investigating the effects of nifedipine, led by researcher Lubsen J. Lubsen J played a key role in the trial as one of the involved researchers. Together, these contributions highlight Lubsen J's leadership and participation in the ACTION trial, which focused on assessing the impact of nifedipine.\",5\n3479,ACTION TRIAL,WAGENER G,Wagener G was a researcher involved in the ACTION trial,5\n3480,ACTION TRIAL,KIRWAN BA,Kirwan BA was a researcher involved in the ACTION trial,5\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_764db194e327af7abcc02440e04d42a607bf506e7cd79a1914d63dcb54f0dce9_v2"}